Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compacting Factor test01:22

Compacting Factor test

The compacting factor test is a method used to assess the workability of concrete. It is  especially suitable for concrete mixes containing aggregates up to one and a half inches in size. This test involves specialized equipment consisting of two truncated cone-shaped hoppers and a cylinder, all with polished interior surfaces to minimize friction.
The procedure begins by placing concrete into the upper hopper without any compaction. Once filled, the bottom door of this hopper is opened,...
Power Factor Correction01:20

Power Factor Correction

The power transmission to a factory involves the transfer of apparent power, a combination of active and reactive power. The power factor measures how effectively electrical power is converted into useful work output. The ratio of the real power (KW) that does the work to the apparent power (KVA) supplied to the circuit.
Factors Affecting Activity Coefficient01:17

Factors Affecting Activity Coefficient

The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size. 
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a decrease in the...
Stress Concentrations01:13

Stress Concentrations

The concept of stress concentration is crucial for understanding how materials respond under bending stresses, particularly when there are irregularities or discontinuities in the material's geometry. Normally, stress in a symmetric member subjected to pure bending is assumed to be uniformly distributed across the entire cross-section. However, this assumption does not hold when there are variations in the cross-sectional geometry or the presence of notches and holes.
The stress concentration...
Stress Concentrations01:24

Stress Concentrations

Stress concentration is when stress intensifies near discontinuities such as holes or abrupt cross-sectional changes in a structural member. This localized stress can often surpass the average stress within the member. The stress distribution in flat bars, either with a circular hole or varying widths connected by fillets, can be determined experimentally using a photoelastic method. The results are based on ratios of geometric parameters like the ratio of the hole's radius to the smaller width...
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A.

Blood·2022
Same author

Genetic regulation of plasma von Willebrand factor levels in health and disease.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The Jamaican Haemophilia Registry: Describing the burden of disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

World bleeding disorders registry: The pilot study.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2017
Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026
Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

A Small Volume Procedure for Viral Concentration from Water
07:28

A Small Volume Procedure for Viral Concentration from Water

Published on: February 3, 2015

The improved factor concentrate.

D Lillicrap1

  • 1Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen's University, Kingston, Canada K7L 3N6. lillicrap@cliff.path.queensu.ca

Hamostaseologie
|January 20, 2009
PubMed
Summary
This summary is machine-generated.

Current haemophilia treatments require frequent infusions and face challenges with antibody development and limited access. New research focuses on developing improved coagulation concentrates with longer half-lives and reduced immunogenicity for better patient care.

More Related Videos

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

Related Experiment Videos

Last Updated: Jun 26, 2026

A Small Volume Procedure for Viral Concentration from Water
07:28

A Small Volume Procedure for Viral Concentration from Water

Published on: February 3, 2015

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

Area of Science:

  • Hematology
  • Biotechnology
  • Pharmaceutical Sciences

Background:

  • Current coagulation protein replacement therapy for hemophilia is effective but requires frequent intravenous infusions.
  • A significant challenge is the development of neutralizing antibodies (inhibitors) in approximately 25% of hemophilia A patients.
  • Limited availability and high cost restrict access to hemophilia treatment for over 70% of the global patient population.

Purpose of the Study:

  • To explore the development of novel coagulation concentrates with enhanced biological properties.
  • To improve the quality of care for individuals with hemophilia.
  • To address limitations of current replacement therapies, including immunogenicity and accessibility.

Main Methods:

  • Investigating improved biosynthetic processes for coagulation factors.
  • Developing strategies to prolong the circulating half-life of replacement proteins.
  • Exploring methods to reduce the immunogenicity of coagulation concentrates.

Main Results:

  • Ongoing research focuses on enhancing coagulation factor properties.
  • Potential improvements include extended duration of action and decreased antibody formation.
  • Efforts aim to increase the availability and reduce the cost of hemophilia therapies.

Conclusions:

  • New approaches are being developed to overcome the limitations of current hemophilia treatments.
  • Enhanced coagulation concentrates promise improved efficacy, safety, and accessibility.
  • Future therapies aim for broader global access and better patient outcomes.